Verastem (VSTM) Enterprise Value (2012 - 2026)
Verastem (VSTM) posted quarterly Enterprise Value of -$197.8 million for Q1 2026, down 68.26% year-over-year from -$623.4 million in Q1 2025, and up 3.49% quarter-over-quarter from -$205.0 million in Q4 2025.
Analysis
Verastem (VSTM) Enterprise Value (2012 - 2026) Analysis & Trends
Verastem's Enterprise Value history runs 16 years deep, the most recent figure standing at -$197.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 68.26% year-over-year to -$197.8 million; the TTM figure through Mar 2026 stood at -$197.8 million (down 68.26% YoY), while the FY2025 annual figure was -$205.0 million, down 130.8% from the prior year.
- Enterprise Value for Q1 2026 stood at -$197.8 million, up from -$205.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$83.4 million in Q2 2024, with the low at -$205.0 million in Q4 2025.
- The 5-year median for Enterprise Value is -$113.2 million (2024), against an average of -$130.1 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 54.46% in 2024, then tumbled 130.8% in 2025.
- Verastem's Enterprise Value stood at -$92.0 million in 2022, then slumped by 48.99% to -$137.1 million in 2023, then soared by 35.23% to -$88.8 million in 2024, then plunged by 130.8% to -$205.0 million in 2025, then increased by 3.49% to -$197.8 million in 2026.
- Business Quant data shows VSTM's Enterprise Value at -$197.8 million in Q1 2026, -$205.0 million in Q4 2025, and -$137.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 209.29 Mn |
| Mar 31, 2026 | 267.74 Mn |
| Dec 31, 2025 | 395.16 Mn |
| Sep 30, 2025 | 451.69 Mn |
| Jun 30, 2025 | 91.00 Mn |
| Mar 31, 2025 | 192.92 Mn |
| Dec 31, 2024 | 95.82 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | -3.28 Mn |
| Mar 31, 2024 | 188.51 Mn |
| Dec 31, 2023 | 68.66 Mn |
| Sep 30, 2023 | 39.74 Mn |
| Jun 30, 2023 | -51.16 Mn |
| Mar 31, 2023 | -26.98 Mn |
| Dec 31, 2022 | -7.68 Mn |
| Sep 30, 2022 | 74.59 Mn |
| Jun 30, 2022 | 123.32 Mn |
| Mar 31, 2022 | 156.44 Mn |
| Dec 31, 2021 | 279.57 Mn |
| Sep 30, 2021 | 457.60 Mn |